Study Design
draftURL
http://hl7.org/fhir/ValueSet/study-design
Version5.0.0
PublisherHL7 (FHIR Project)Date2022-08-24T12:40:00+00:00DescriptionThis is a set of terms for study design characteristics.
Expansion
| Code | Display | System |
|---|---|---|
| SEVCO:01001 | Interventional research | http://hl7.org/fhir/study-design |
| SEVCO:01003 | randomized assignment | http://hl7.org/fhir/study-design |
| SEVCO:01006 | simple randomization | http://hl7.org/fhir/study-design |
| SEVCO:01007 | stratified randomization | http://hl7.org/fhir/study-design |
| SEVCO:01008 | block randomization | http://hl7.org/fhir/study-design |
| SEVCO:01009 | adaptive randomization | http://hl7.org/fhir/study-design |
| SEVCO:01005 | Non-randomized assignment | http://hl7.org/fhir/study-design |
| SEVCO:01004 | Quasi-Randomized assignment | http://hl7.org/fhir/study-design |
| SEVCO:01029 | Clinical trial | http://hl7.org/fhir/study-design |
| SEVCO:01041 | Pragmatic clinical trial | http://hl7.org/fhir/study-design |
| SEVCO:01038 | Expanded Access study | http://hl7.org/fhir/study-design |
| SEVCO:01030 | Phase 1 trial | http://hl7.org/fhir/study-design |
| SEVCO:01031 | Exploratory investigational new drug study | http://hl7.org/fhir/study-design |
| SEVCO:01032 | Phase 1/Phase 2 trial | http://hl7.org/fhir/study-design |
| SEVCO:01033 | Phase 2 trial | http://hl7.org/fhir/study-design |
| SEVCO:01034 | Phase 2/Phase 3 trial | http://hl7.org/fhir/study-design |
| SEVCO:01035 | Phase 3 Trial | http://hl7.org/fhir/study-design |
| SEVCO:01036 | Post-marketing study | http://hl7.org/fhir/study-design |
| SEVCO:01002 | Observational research | http://hl7.org/fhir/study-design |
| SEVCO:01037 | Post-Marketing Surveillance study | http://hl7.org/fhir/study-design |